Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Folic acid

This article was originally published in The Tan Sheet

Executive Summary

FDA June 17 memo informs members of the agency's Food Advisory Committee as well as outside scientific experts of an upcoming meeting to discuss folic health claims for the prevention of neural tube defects. FDA said June 15 that it will obtain advice from the advisory groups at approximately mid-point in the comment period of a July proposal to allow health claims for folic acid ("The Tan Sheet" June 21, p. 5). The memo recipients also were asked to identify issues and concerns regarding folic acid that they believe should be addressed by FDA...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS081609

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel